Document is current

Article History

Received: 26 August 2024

Accepted: 7 February 2025

First Online: 5 March 2025

Change Date: 5 July 2025

Change Type: Update

Change Details: This article has been updated to amend the license information

Declarations

:

: The study design was based on the guidelines for evaluating the target animal safety of new pharmaceuticals (VICH Guideline 43), and recognized quality assurance standards (United States Food and Drug Administration (FDA) Good Laboratory Practice (GLP) Regulations, 21 Code of Federal Regulations (CFR) Part 58 and the Organization for Economic Cooperation and Development (OECD) Series on Principles of Good Laboratory Practice and Compliance Monitoring, Number 13). The study was conducted at an AAALAC accredited facility and approved by their Institutional Animal Care and Use Committee. This manuscript was prepared in compliance with the ARRIVE Guidelines.

: Not applicable.

: The authors declare no competing interests.